ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -53.4% | 19,636 | 0.0% | 0.00% | – |
| Q3 2021 | $58,000 | -79.4% | 19,636 | -75.6% | 0.00% | – |
| Q2 2021 | $281,000 | -36.9% | 80,436 | -38.2% | 0.00% | – |
| Q1 2021 | $445,000 | -81.3% | 130,054 | +4.7% | 0.00% | -100.0% |
| Q4 2020 | $2,386,000 | +102.5% | 124,270 | +41.8% | 0.00% | 0.0% |
| Q3 2020 | $1,178,000 | -65.8% | 87,656 | +7.7% | 0.00% | -50.0% |
| Q2 2020 | $3,448,000 | +86.8% | 81,422 | +21.8% | 0.00% | +100.0% |
| Q1 2020 | $1,846,000 | -19.7% | 66,830 | -5.7% | 0.00% | 0.0% |
| Q4 2019 | $2,300,000 | +27.8% | 70,877 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $1,800,000 | -11.2% | 69,141 | +25.2% | 0.00% | 0.0% |
| Q2 2019 | $2,026,000 | +69.4% | 55,205 | +2.1% | 0.00% | 0.0% |
| Q1 2019 | $1,196,000 | +75.1% | 54,055 | +11.5% | 0.00% | 0.0% |
| Q4 2018 | $683,000 | -23.0% | 48,489 | +6.2% | 0.00% | 0.0% |
| Q3 2018 | $887,000 | +17.6% | 45,664 | +33.8% | 0.00% | 0.0% |
| Q2 2018 | $754,000 | +24.6% | 34,137 | +19.6% | 0.00% | – |
| Q1 2018 | $605,000 | – | 28,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |